Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Hemorrhage 2Urinary Bladder Neoplasms 1Rectal Neoplasms 1Prostatic Neoplasms 1Primary Peritoneal Neoplasm 1Postoperative Complications 1Neoplasm Metastasis 1Ischemia 1Hearing Loss 1Fluid and Electrolyte Imbalance 1Ear Neoplasms 1Diverticulitis 1Crohn Disease 1Colonic Polyps 1Colonic Neoplasms 1Colitis, Ulcerative 1Blood Loss, Surgical 1

Interventions

Misoprostol 3Tranexamic Acid 2Saline Solution 2Aprotinin 2maleimide-polyethylene glycol-modified hemoglobin, MP4 1carbetocin 1Vasopressins 1Uterine Myomectomy 1Tourniquets 1Tidal Volume 1Terlipressin 1Sodium Chloride 1Ringer's Solution 1Ringer's Lactate 1Population Groups 1Oxytocin 1Neuromuscular Blockade 1Ethamsylate 1Embolization, Therapeutic 1Cerebral Angiography 1Bupivacaine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Blood Loss, Surgical × Ringer's Lactate × Clear all
NCT00425334 2013-08-19

Safety Study of HemospanĀ® in Prostatectomy Patients

Sangart

Phase 2 Completed
20 enrolled
Genitourinary

Hemorrhage, Ischemia, Prostatic Neoplasms, Blood Loss, Surgical

Data powered by HemOnc (CC BY 4.0) Colophon ⚔